SCHEMBL6559702

SCHEMBL6559702

CN(C)c1ccc(C(O)Cc2ccccn2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 3/20 0.52
▸ MAOB P27338 3/20 0.52
▸ NPC1 O15118 3/20 0.50
▸ RAB9A P51151 3/20 0.50
▸ PTPRA P18433 1/20 0.46
▸ KDM4E B2RXH2 3/20 0.46
▸ GRIN2D O15399 1/20 0.44
▸ GRIN3B O60391 1/20 0.44
▸ GRIN1 Q05586 1/20 0.44
▸ GRIN2A Q12879 1/20 0.44
▸ GRIN2B Q13224 1/20 0.44
▸ GRIN2C Q14957 1/20 0.44
▸ GRIN3A Q8TCU5 1/20 0.44
▸ FDPS P14324 1/20 0.43
▸ MAPT P10636 2/20 0.43
▸ GAA P10253 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ MITF O75030 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL5949407 0.98 MAOA (0.51) MAOAMAOBNPC1RAB9APTPRA
SCHEMBL9491676 0.82 KDM4E (0.63) MAOAMAOBPTPRAKDM4EGRIN2D
SCHEMBL22728750 0.82 KDM4E (0.63) MAOAMAOBPTPRAKDM4EGRIN2D
SCHEMBL27701885 0.81 MAOA (0.49) MAOAMAOBNPC1RAB9APTPRA
SCHEMBL5949509 0.80 IGF1R (0.50) PTPRAKDM4EGRIN2DGRIN3BGRIN1
SCHEMBL5949323 0.80 IGF1R (0.50) PTPRAKDM4EGRIN2DGRIN3BGRIN1
SCHEMBL5948990 0.80 IGF1R (0.50) PTPRAKDM4EGRIN2DGRIN3BGRIN1
SCHEMBL5949524 0.79 PTPRA (0.46) NPC1RAB9APTPRAKDM4EGRIN2D
SCHEMBL11084913 0.79 MEN1 (0.50) NPC1RAB9APTPRAKDM4EGRIN2D
SCHEMBL27701887 0.78 MAOA (0.49) MAOAMAOBNPC1RAB9APTPRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100371326-C New substituted pyridine or pyridine compound, their producing process and pharmaceutical composition containing them ADIR (FR) 2008-02-27 — — CN claimed
EP-1050531-B1 Pyridine and piperidine derivatives for treating neurodegenerative diseases SERVIER LAB (FR) 2004-11-17 — — EP claimed
EP-1050531-B1 Pyridine and piperidine derivatives for treating neurodegenerative diseases SERVIER LAB (FR) 2004-11-17 — — EP disclosed
EP-1050531-A1 Pyridine and piperidine derivatives for treating neurodegenerative diseases ADIR ET COMPAGNIE (FR) 2000-11-08 — — EP disclosed
Send feedback